Work

Plasma extracellular matrix and inflammatory proteins as biomarkers for diagnosis, differentiation, and risk assessment in pulmonary arterial hypertension - utilizing Lund Cardio Pulmonary Registry

Year: 2024
Type: dissertation
Study design: Observational Study
Abstract: Pulmonary arterial hypertension (PAH) is a rare disease that affects the pulmonary vasculature. Characterized by increased pulmonary arterial pressures and vascular resistance, it causes right heart failure (HF), and premature death. The main symptom, exertional dyspnoea, is non-specific where patient’s and doctor’s delay often lead to diagnosis in advanced stages. Despite development of PAH specific drugs and new treatment strategies, prognosis remains poor. This dissertation aimed toscreen for bloodborne biomarkers with potential to facilitate differentiation between various causes of dyspnoea for earlier diagnosis, and more accurate risk assessment in PAH.Patients with PAH, chronic thromboembolic pulmonary hypertension, pulmonary hypertension (PH) associated with HF with preserved or reduced ejection fraction, and patients with HF without PH who underwent right heart catheterisation as part of investigation for dyspnoea, and healthy controls enrolled in the Lund Cardio Pulmonary Registry were included. Venous blood samples were analysed with proximity extension assays and quantitative PCR. Statistical analyses were used to compare proteins’levels in the different groups and evaluate proteins as discriminators of PAH.In paper I-II, plasma matrix metalloproteinase (MMP)-7 and prolargin were identified as candidates thatcould discriminate PAH from controls and among the other patient groups with dyspnea.In paper III, increased plasma levels of MMP-2, perlecan, and tissue inhibitor of metalloproteinases 4(TIMP-4) were negative predictors of survival. MMP-2 levels at diagnosis correlated with the European3-strata risk assessment score.In paper IV, plasma tumor necrosis factor related apoptosis-inducing ligand (TRAIL) could identify PAHamong the other dyspnea patients and controls. Additionally, annexin A1 was a prognostic marker inPAH.The present thesis provides evidence for several new biomarkers, related to extracellular matrix orinflammation, with a diagnostic and prognostic potential in PAH. Combining multiple proteins in abiomarker panel may further improve the discriminative and/or prognostic ability.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7033037453
Cites: 94
Cited by:
Related to: 10